FGFR1 and urinary bladder carcinoma: Hence, we systematically screened a cohort of squamous differentiated specimens and publically available datasets of “squamous-like” bladder cancers for expression, amplification, mutation and chromosomal rearrangement of FGFRs (FGFR1-3), in order to evaluate putative pathway activation.